LL-K8-22 is a potent, selective and durable PROTAC CDK8-cyclin C dual degrader, with DC50 values of 2.52 and 2.64 µM, respectively. LL-K8-22 also suppresses STAT1 Ser 727 phosphorylation. LL-K8-22 inhibits E2F- and MYC-driven carcinogenic transcriptional programs. LL-K8-22 can be used for triplenegative breast cancer (TNBC) research. (Pink: Ligand for target protein (HY-168683), Black: Linker (HY-Y0340), Blue: Ligand for E3 ligase (HY-N2427)) [1].
Molecular Weight:
573.77
Purity:
99.76
CAS Number:
[3034487-84-5]
Formula:
C37H43N5O
Target:
CDK,Early 2 Factor (E2F),PROTACs,STAT
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted